Severe anemia constitutes the major morbidity/mortality for del(5q) MDS patients and arises from RPS14 haplodeficiency leading to MDM2 sequestration, p53 stabilization, and erythroid cell death. The gene discussed is RPS14; the disease is myelodysplastic syndrome.